Karyopharm Therapeutics (KPTI) PT Raised to $32 at Morgan Stanley

November 3, 2020 4:30 AM EST
Get Alerts KPTI Hot Sheet
Price: $6.09 +0.33%

Rating Summary:
    11 Buy, 3 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 9 | New: 24
Trade Now! 
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $32.00 (from $31.00) while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change